FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER
Go back to FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER| COSTA-A (NASDAQ: ATX) | Delayed: 21.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.49 | 52 Week High | $22.62 | |||
| Open | $21.49 | 52 Week Low | $10.75 | |||
| Day High | $21.49 | P/E | 42.98 | |||
| Day Low | $21.49 | EPS | $0.50 | |||
| Volume | 47,094 | |||||
